全球類器官服務市場

預計到 2030 年全球類器官服務市場規模將達 112 億美元

全球類器官服務市場規模預計在2024年達到36億美元，預計在分析期間（2024-2030年）將以20.9%的複合年成長率成長，到2030年將達到112億美元。腸道是本報告分析的細分市場之一，預計其複合年成長率將達到22.9%，到分析期結束時達到35億美元。肝臟細分市場在分析期間內的複合年成長率預計為21.8%。

美國市場規模估計為 9.794 億美元，中國市場預計複合年成長率為 28.3%

美國類器官服務市場規模預計2024年達到9.794億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到27億美元，在2024-2030年的分析期間內，複合年成長率為28.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為16.5%和18.8%。在歐洲，預計德國市場的複合年成長率約為17.6%。

全球類器官服務市場－主要趨勢與促進因素摘要

為什麼類器官成為生物醫學研究和藥物測試的核心？

類器官服務涉及開發、培養和分析源自人類幹細胞的微型3D生物模型，這些模型能夠重現真實器官的關鍵結構和功能。這些服務透過提供比傳統2D細胞培養或動物模型更俱生理相關性的系統，正在變革藥物研發、疾病建模和精準醫療。

類器官能夠模擬組織特異性結構、細胞多樣性和基因表現模式，因此可用於模擬癌症、神經退化性疾病、感染疾病和罕見遺傳疾病。它們能夠保留患者特異性突變，從而支持個人化醫療應用，即在患者樣本中測試藥物療效和毒性。這提高了臨床前研究的預測準確性，並減少了後期藥物開發的失敗。

技術平台、車型類型、客製化能力如何擴展？

服務供應商提供廣泛的類器官模型，包括使用誘導性多功能幹細胞(iPSC)、成體幹細胞或腫瘤切片檢查構建的腦、肝、腸、胰腺、腎和肺模型。這些模型可以根據疾病類型、突變譜和治療標靶進行標準化或客製化。先進的成像、多組體學和功能分析整合在一起，用於監測藥物反應和組織動力學。

配備自動化液體處理和人工智慧輔助數據分析的高通量篩檢平台正在提高基於類器官檢測的可擴展性和可重複性。新興趨勢包括類器官與微流體晶片的整合（器官晶片系統）、與免疫細胞的共培養模型、長期部署方案。服務供應商也支持產生患者特異性類器官，用於基因編輯、生物樣本庫和臨床研究。

該服務將在哪些地方應用？主要應用領域有哪些？

類器官服務在製藥公司、學術研究機構、受託研究機構和精準醫療新興企業中迅速普及。腫瘤學是最大的應用領域，腫瘤衍生的類器官被廣泛用於測試癌症治療方案、預測患者反應以及開發伴隨診斷。由於類器官能夠有效複製複雜的組織行為，對胃腸道和神經系統疾病的研究也不斷擴展。

北美和歐洲是關鍵市場，得益於強大的學術基礎設施、生物技術投資以及監管機構對替代檢測方法的積極參與。亞太地區正經歷著成長，這得益於政府支持的幹細胞計畫以及對再生醫學和藥物篩檢投資的不斷增加。合作研究網路以及與生物製藥公司的合作關係正在加速類器官檢測服務在轉化研究中的應用。

類器官服務市場的成長受到多種因素的推動。

類器官服務市場的成長受到許多因素的推動，例如對生理精準疾病模型的需求、對個人化藥物篩檢平台日益成長的需求，以及利用幹細胞和患者來源組織的3D培養技術的進步。高通量分析工具的擴展及其與成像、基因組學和轉錄組學的整合，為複雜的功能測試提供了支持。

動物模型的局限性以及對符合倫理的檢測要求，推動了腫瘤學、神經生物學和感染疾病研究的發展。類器官研發資金的增加、監管機構對無動物檢測方法的鼓勵，以及服務供應商和製藥公司之間的合作，進一步刺激了全球需求。可擴展性、冷凍保存和通訊協定標準化方面的改進，使其在研究和臨床環境中的應用更加廣泛。

部分

器官類型（腸、肝、胃、胰臟、肺、腦、腎臟）、來源（多功能細胞、器官特異性成體幹細胞）、應用（發育生物學疾病應用、感染疾病病理學應用、再生醫學應用、藥物毒性和療效測試應用、藥物發現和個人化醫療應用）

受訪公司範例

• ATCC
• Crown Bioscience
• DefiniGEN
• Emulate Inc.
• GenScript Biotech Corporation
• HUB Organoids
• InSphero AG
• Inventia Life Science
• JSR Life Sciences
• Kirkstall Ltd.
• Lifeline Cell Technology
• MIMETAS
• Molecular Devices
• Organovo Holdings, Inc.
• Pionyr Immunotherapeutics
• Prellis Biologics, Inc.
• ReproCELL Inc.
• STEMCELL Technologies Inc.
• TissUse GmbH
• Visikol Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Organoids Services Market to Reach US$11.2 Billion by 2030

The global market for Organoids Services estimated at US$3.6 Billion in the year 2024, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 20.9% over the analysis period 2024-2030. Intestine, one of the segments analyzed in the report, is expected to record a 22.9% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Liver segment is estimated at 21.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$979.4 Million While China is Forecast to Grow at 28.3% CAGR

The Organoids Services market in the U.S. is estimated at US$979.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 28.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 18.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.6% CAGR.

Global Organoids Services Market - Key Trends & Drivers Summarized

Why Are Organoids Becoming Central to Biomedical Research and Drug Testing?

Organoid services involve the development, culture, and analysis of miniaturized, three-dimensional biological models derived from human stem cells that replicate key structural and functional aspects of real organs. These services are transforming drug discovery, disease modeling, and precision medicine by offering more physiologically relevant systems than conventional 2D cell cultures or animal models.

Organoids mimic tissue-specific architecture, cellular diversity, and genetic expression patterns, making them valuable for modeling cancer, neurodegenerative conditions, infectious diseases, and rare genetic disorders. Their ability to retain patient-specific mutations supports personalized medicine applications, where drug efficacy and toxicity can be tested on patient-derived samples. This enhances the predictive accuracy of preclinical research and reduces late-stage drug development failures.

How Are Technology Platforms, Model Types, and Customization Capabilities Expanding?

Service providers are offering a broad range of organoid types, including brain, liver, intestinal, pancreatic, kidney, and lung models, built using induced pluripotent stem cells (iPSCs), adult stem cells, or tumor biopsies. These models can be standardized or customized based on disease type, mutation profile, or therapeutic target. Advanced imaging, multi-omics profiling, and functional assays are integrated to monitor drug responses and tissue dynamics.

High-throughput screening platforms compatible with automated liquid handling and AI-assisted data analytics are enhancing the scalability and reproducibility of organoid-based testing. Emerging trends include integration of organoids with microfluidic chips (organ-on-a-chip systems), co-culture models with immune cells, and long-term expansion protocols. Service providers are also supporting gene editing, biobanking, and patient-specific organoid generation for clinical research.

Where Are Services Gaining Adoption and What Are the Primary Application Areas?

Organoid services are seeing rapid uptake among pharmaceutical companies, academic research institutions, contract research organizations, and precision medicine startups. Oncology is the largest application area, with widespread use of tumor-derived organoids for testing cancer therapies, predicting patient response, and developing companion diagnostics. Gastrointestinal and neurological disease research is also expanding due to the complex tissue behaviors that organoids replicate effectively.

North America and Europe are leading markets, supported by strong academic infrastructure, biotech investment, and regulatory engagement in alternative testing methods. Asia-Pacific is experiencing growth through government-backed stem cell initiatives and increasing investment in regenerative medicine and drug screening. Collaborative research networks and biopharma alliances are accelerating the availability of organoid testing services in translational research.

Growth in the Organoids Services market is driven by several factors…

Growth in the organoids services market is driven by factors such as demand for physiologically accurate disease models, rising need for personalized drug screening platforms, and advances in 3D culture techniques using stem cells and patient-derived tissues. Expansion of high-throughput analysis tools and integration with imaging, genomics, and transcriptomics is supporting complex functional testing.

Adoption in oncology, neurobiology, and infectious disease research is being accelerated by the limitations of animal models and the push for ethically compliant testing. Increased funding for organoid-based R&D, regulatory encouragement for non-animal testing methods, and collaborations between service providers and pharmaceutical companies are further stimulating global demand. Improvements in scalability, cryopreservation, and protocol standardization are enabling broader accessibility across research and clinical domains.

SCOPE OF STUDY:

The report analyzes the Organoids Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney); Source (Pluripotent Stem Cells, Organ Specific Adult Stem Cell); Application (Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application, Drug Discovery & Personalized Medicine Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• ATCC
• Crown Bioscience
• DefiniGEN
• Emulate Inc.
• GenScript Biotech Corporation
• HUB Organoids
• InSphero AG
• Inventia Life Science
• JSR Life Sciences
• Kirkstall Ltd.
• Lifeline Cell Technology
• MIMETAS
• Molecular Devices
• Organovo Holdings, Inc.
• Pionyr Immunotherapeutics
• Prellis Biologics, Inc.
• ReproCELL Inc.
• STEMCELL Technologies Inc.
• TissUse GmbH
• Visikol Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Organoids Services - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Physiologically Relevant In Vitro Models Spurs Growth in Organoid-Based Research Services
  • Advancements in 3D Cell Culture and Tissue Engineering Strengthen Business Case for Organoid Platforms
  • Expansion of Precision Medicine and Drug Screening Applications Throws the Spotlight on Patient-Derived Organoids
  • Increasing Limitations of Traditional Animal Models Propel Adoption of Human-Like Organoid Systems
  • Growth in Oncology Research and Personalized Therapeutics Enhances Use of Tumor Organoid Services
  • Rising Investment in Biopharma R&D and Preclinical Testing Supports Outsourcing to Organoid Service Providers
  • Use of Organoids in Infectious Disease Modeling and Vaccine Development Expands Research Applications
  • AI Integration in Organoid Imaging and Data Analysis Strengthens High-Throughput Screening Capabilities
  • Technological Integration with CRISPR and Genomic Editing Tools Enhances Functional Organoid Research
  • Growing Demand for Toxicology and Drug Metabolism Studies Drives Use of Liver and Kidney Organoids
  • Development of Organ-on-a-Chip Hybrids Broadens Scope for Multi-Organ Testing Models
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Organoids Services Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Organoids Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Brain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Brain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Brain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Developmental Biology Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Developmental Biology Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Developmental Biology Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Pathology of Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Pathology of Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Pathology of Infectious Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Regenerative Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Regenerative Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Regenerative Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Drug Toxicity & Efficacy Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Drug Toxicity & Efficacy Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Drug Toxicity & Efficacy Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Drug Discovery & Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Drug Discovery & Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Drug Discovery & Personalized Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Pluripotent Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Pluripotent Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Pluripotent Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Organ Specific Adult Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Organ Specific Adult Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Organ Specific Adult Stem Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• JAPAN
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• CHINA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• EUROPE
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Organoids Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• FRANCE
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: France 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• GERMANY
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Germany 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Italy 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: UK 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Spain 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Russia 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Organoids Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Australia 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• INDIA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: India 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: South Korea 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Organoids Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Latin America 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Argentina 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Brazil 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Mexico 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Organoids Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Middle East 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Iran 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Israel 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: UAE 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• AFRICA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Africa 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030

IV. COMPETITION